Digital health startup Atropos Health received an investment of 14 million dollars . The $14 million Series A funding round was led by Breyer Capital, with participation from Emerson Collective and Boston Millennia Partners. The US-based company announced that it will use the new investment in its research on cancer treatment. It also announced that the company has appointed one of the founding partners, Brigham Hyde, as CEO.
Atropos Health was founded in 2020 by three entrepreneurs Brigham Hyde, Nigam Shah and Saurabh Gombar. The company is working on rare diseases that do not have a definite cure. A significant number of rare diseases involve a chronic process with no definitive cure.
While the origin, cause, natural history and epidemiological data of the disease vary greatly, for some diseases this most basic information is limited. At this point, the application developed by Altropos comes into play. The app allows doctors to access research on any rare disease. Doctors’ questions are answered, reports are presented about patients who have experienced the same situation in the past.
Last March, health technology company Altibbi announced that it had received $44 million in investment . The round was led by Foundation Holdings, Hikma Ventures, Global Ventures and DASH Ventures. The new investment will be used to expand its field of activity. After the investment round, Foundation Holdings Senior Advisor Jason Kothari will join Altibbi’s board of directors. The United Arab Emirates-based company has so far received an investment of $52.2 million.
Jalil Allabadi, Founder and CEO of Altibbi, said: “We are excited to complete the funding round made up of leading financial and strategic investors with strong healthcare and technology expertise.” Founded in 2011, Altibbi is positioned as a telehealth healthcare initiative. The company provides the opportunity to access the developments in the field of medicine, diseases and health data.